CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression

Ming Ji, Liyuan Wang, Ju Chen, Nina Xue, Chunyang Wang, Fangfang Lai, Rubing Wang, Shishan Yu, Jing Jin, Xiaoguang Chen
  • OncoTargets and Therapy, June 2018, Dove Medical Press
  • DOI: 10.2147/ott.s163535

The authors haven't yet claimed this publication.

open access logoRead Publication

http://dx.doi.org/10.2147/ott.s163535

In partnership with: